BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
1-Year Return
16.47%
This Quarter Return
+3.38%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$2.49B
AUM Growth
+$450M
(+22%)
Cap. Flow
+$405M
Cap. Flow
% of AUM
16.29%
Top 10 Holdings %
Top 10 Hldgs %
43.41%
Holding
209
New
33
Increased
83
Reduced
31
Closed
36
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$139M |
| 2 |
Citigroup
C
|
+$31.7M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$28.7M |
| 4 |
Linde
LIN
|
+$16.9M |
| 5 |
Microsoft
MSFT
|
+$16.2M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$24.7M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.3M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$8.16M |
| 4 |
Zebra Technologies
ZBRA
|
+$5.33M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$4.79M |
Sector Composition
| 1 | Healthcare | 23.1% |
| 2 | Technology | 17.53% |
| 3 | Consumer Discretionary | 14.48% |
| 4 | Communication Services | 12.6% |
| 5 | Financials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
126
DELISTED
Abiomed Inc
ABMD
| $496K | 0.02% |
+1,556
| New | +$496K |
|
127
Akamai
AKAM
$11B
| $489K | 0.02% |
4,796
+2,219
| +86% | +$226K |
|
128
Netflix
NFLX
$505B
| $459K | 0.02% |
880
-506
| -37% | -$264K |
|
129
Invesco S&P 500 Equal Weight ETF
RSP
$74.7B
| $421K | 0.02% |
2,971
+550
| +23% | +$77.9K |
|
130
iRhythm Technologies
IRTC
$5.78B
| $411K | 0.02% |
+2,963
| New | +$411K |
|
131
Tandem Diabetes Care
TNDM
$829M
| $406K | 0.02% |
+4,600
| New | +$406K |
|
132
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.4B
| $399K | 0.02% |
4,832
| – | – |
|
133
Amgen
AMGN
$149B
| $390K | 0.02% |
1,568
+480
| +44% | +$119K |
|
134
10x Genomics
TXG
$1.57B
| $379K | 0.02% |
+2,092
| New | +$379K |
|
135
iShares Core US Aggregate Bond ETF
AGG
$132B
| $377K | 0.02% |
3,312
| – | – |
|
136
Eli Lilly
LLY
$677B
| $374K | 0.02% |
2,000
| – | – |
|
137
Pacific Biosciences
PACB
$351M
| $374K | 0.02% |
+11,232
| New | +$374K |
|
138
Ross Stores
ROST
$48.4B
| $374K | 0.02% |
3,119
-900
| -22% | -$108K |
|
139
Lockheed Martin
LMT
$110B
| $370K | 0.01% |
+1,000
| New | +$370K |
|
140
Moderna
MRNA
$9.15B
| $369K | 0.01% |
+2,820
| New | +$369K |
|
141
UBS Group
UBS
$129B
| $365K | 0.01% |
23,470
-16,600
| -41% | -$258K |
|
142
Trane Technologies
TT
$89.2B
| $363K | 0.01% |
2,193
+461
| +27% | +$76.3K |
|
143
AbbVie
ABBV
$386B
| $350K | 0.01% |
+3,230
| New | +$350K |
|
144
Perrigo
PRGO
$3.06B
| $350K | 0.01% |
8,650
| – | – |
|
145
Xylem
XYL
$34.5B
| $349K | 0.01% |
3,316
+784
| +31% | +$82.5K |
|
146
Teladoc Health
TDOC
$1.36B
| $347K | 0.01% |
+1,909
| New | +$347K |
|
147
Insulet
PODD
$24.1B
| $344K | 0.01% |
+1,319
| New | +$344K |
|
148
Apellis Pharmaceuticals
APLS
$3.14B
| $338K | 0.01% |
+7,881
| New | +$338K |
|
149
Dropbox
DBX
$8.34B
| $321K | 0.01% |
+12,051
| New | +$321K |
|
150
QuidelOrtho
QDEL
$1.94B
| $315K | 0.01% |
+2,462
| New | +$315K |
|